BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  ImmunoMet Appoints Benjamin R. Cowen, PhD, MBA, as CEO

  ImmunoMet Therapeutics today announced the appointment of Benjamin R. Cowen, PhD, MBA, as CEO, effective November 1, 2017.

  November 1, 2017

   · 

  3 min read
• Business

  Tenaya Therapeutics Appoints Tim Hoey, Ph.D. as CSO

  Dr. Hoey is a biopharmaceutical executive with over two decades of experience in the industry.

  November 1, 2017

   · 

  2 min read
• Drug Development

  Theravance Biopharma and Mylan Report Additional Positive Phase III Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting

  James F. Donohue, MD, Professor of Medicine, Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill, presented new data from the completed three-month Phase III studies.

  November 1, 2017

   · 

  15 min read
• Pharm Country

  Genisphere Raises $7M to Advance 3DNA Drug Delivery System

  Genisphere completed the raise to support accelerating interest in advancing its 3DNA scaffold into the clinic and enabling follow-on studies and programs currently underway with biotech and pharma partners.

  November 1, 2017

   · 

  2 min read
• 

  FDA

  IntraFuse Receives FDA Clearance for FlexThread Fibula Pin System

  IntraFuse received FDA approval for its FlexThread Fibula Pin System which provides percutaneous fixation of distal fibula fractures.

  November 1, 2017

   · 

  3 min read
• Business

  Cytel Announces Partnership With New Mountain Capital

  Cytel announced that it has partnered with New Mountain Capital, a growth-oriented investment firm that currently manages over $20 billion in assets.

  November 1, 2017

   · 

  4 min read
• BioMidwest

  Johnson & Johnson Gets in on On Target Laboratories’ $40M Funding Round

  The company will use the funding to further develop its lead imaging compound, OTL38, for use in detecting multiple cancers.

  November 1, 2017

   · 

  1 min read
• Policy

  Kitov Pharma Announces Receipt of FDA’s Favorable Response to NT219’s Pre-IND Meeting Package

  FDA has agreed to the proposed CMC, preclinical, and clinical development plans for NT219.

  November 1, 2017

   · 

  7 min read
• Pharm Country

  Syntimmune Announces Clinical Data from First-in-Human Trial of Lead Candidate SYNT001

  An abstract of the Phase Ia trial results was posted today on the ASH website in advance of a poster presentation of the data, which will take place during the 59th ASH Annual Meeting, to be held in Atlanta, December 9-12.

  November 1, 2017

   · 

  7 min read
• Business

  MC10 Enters Strategic Collaboration With LabCorp, Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics

  As part of the collaboration, LabCorp has also made an equity investment into MC10.

  November 1, 2017

   · 

  3 min read